JOHANNESBURG (AP) – After a false start and an unconventional test run, South Africa on Friday announced the This week South Africa finalized the purchases of 51 million doses: 31 million of Johnson & Johnson’s one-dose vaccine and 20 million of Pfizer’s two-dose vaccine, Mkhize said. South Africa’s vaccination campaign has been moving slowly, but it will accelerate with deliveries this of 3 million J&J; doses and 6 million Pfizer doses, Mkhize said. Further deliveries will cover the bulk of the government’s aim to inoculate 67% of the country’s 60 by early 2022.to inoculate more than 40 million people by February next year. “We have now secured adequate vaccines and can move ahead with confidence with our mass rollout campaign,” Zweli Mkhize said during a presentation to civic groups and others.
Criticism has mounted, from leading health professionals and ordinary South Africans, over the slow nearly half the continent’s deaths from the disease. Health experts warn that South Africa could face a resurgence of infections following the Easter holiday and as cold weather approaches in the Southern Hemisphere’s winter months. The country’s 1.2 million are being vaccinated in the first phase.. South Africa has by far the most considerable burden of COVID-19 in Africa. With more than 1.5 million confirmed cases, including 53,173 deaths, the country cases reported by the continent’s 54 countries. South Africa accounts for
To date, just over 283,000 health care workers have been vaccinated since mid-February, when the government began giving J&J; doses as a large-scalehad not yet been approved for general use. The slow pace of just over 6,000 shots administered per of J&J; doses, which have come in small batches. , clinics, doctors’ offices, pharmacies, shopping centers and workplaces, Mkhize said.
The mass vaccinations will begin in mid-May with the start of the second phase in which 16.6 million elderly, health care workers, following the results of a minor, preliminary test that indicated the vaccine was ineffective in preventing mild to moderate cases of COVID-19 caused by the variant dominant in the country.and others at risk will get jabs. In October, will begin vaccinating the remainder of its adults, about 22.6 million people, to finish that in February 2022. South Africa’s vaccinations got off to a rocky start in February when the use of the AstraZeneca vaccine was scrapped just days before it was to be given to